Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q03518: Variant p.Val458Leu

Antigen peptide transporter 1
Gene: TAP1
Feedback?
Variant information Variant position: help 458 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Valine (V) to Leucine (L) at position 458 (V458L, p.Val458Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Polymorphism: help There are five common alleles; TAP1*01:01 (PSF1A), TAP1*02:01 (PSF1B), TAP1*03:01 (PSF1C), TAP1*01:04 and TAP1*x. The sequence of TAP1*01:01 is shown here. Additional information on the polymorphism described.
Variant description: help In allele TAP1*04:01. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 458 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 748 The length of the canonical sequence.
Location on the sequence: help AVSSGNLVTFVLYQMQFTQA V EVLLSIYPRVQKAVGSSEKI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 748 Antigen peptide transporter 1
Transmembrane 444 – 464 Helical; Name=10
Domain 187 – 470 ABC transmembrane type-1
Region 453 – 487 Part of the peptide-binding site



Literature citations
TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility.
Jackson D.G.; Capra J.D.;
Proc. Natl. Acad. Sci. U.S.A. 90:11079-11083(1993)
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANTS VAL-333; LEU-458; GLY-637 AND GLN-648; POLYMORPHISM; TAP1 polymorphisms in several human ethnic groups: characteristics, evolution, and genotyping strategies.
Tang J.; Freedman D.O.; Allen S.; Karita E.; Musonda R.; Braga C.; Margolick J.; Kaslow R.A.;
Hum. Immunol. 62:256-268(2001)
Cited for: VARIANTS VAL-333; VAL-370; LEU-458; ILE-518; GLY-637 AND GLN-648; POLYMORPHISM; Novel TAP1 polymorphisms in indigenous Zimbabweans: their potential implications on TAP function and in human diseases.
Lajoie J.; Zijenah L.S.; Faucher M.C.; Ward B.J.; Roger M.;
Hum. Immunol. 64:823-829(2003)
Cited for: VARIANTS SER-7; ARG-17; VAL-333; VAL-370; CYS-419; LEU-458; GLY-637 AND GLN-648; POLYMORPHISM;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.